Friederike Sixel-Doring
Overview
Explore the profile of Friederike Sixel-Doring including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
80
Citations
2240
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fanciulli A, Sixel-Doring F, Buhmann C, Krismer F, Hermann W, Winkler C, et al.
J Neurol
. 2025 Jan;
272(1):90.
PMID: 39751950
Background And Objective: Non-motor symptoms frequently develop throughout the disease course of Parkinson's disease (PD), and pose affected individuals at risk of complications, more rapid disease progression and poorer quality...
2.
Jarski P, Gasimov T, Dragaescu C, Sixel-Doring F, von Eckardstein K, Mollenhauer B, et al.
Mov Disord Clin Pract
. 2024 Dec;
PMID: 39629747
Background: Leucencephalopathy (LE) is often detected on magnetic resonance imaging in elderly patients. These white matter lesions may interfere with lead trajectories for deep brain stimulation (DBS) in patients with...
3.
Bartl M, Nilsson J, Dakna M, Weber S, Schade S, Xylaki M, et al.
NPJ Parkinsons Dis
. 2024 Jun;
10(1):121.
PMID: 38918412
No abstract available.
4.
Hallqvist J, Bartl M, Dakna M, Schade S, Garagnani P, Bacalini M, et al.
Nat Commun
. 2024 Jun;
15(1):4759.
PMID: 38890280
Parkinson's disease is increasingly prevalent. It progresses from the pre-motor stage (characterised by non-motor symptoms like REM sleep behaviour disorder), to the disabling motor stage. We need objective biomarkers for...
5.
Bartl M, Nilsson J, Dakna M, Weber S, Schade S, Xylaki M, et al.
NPJ Parkinsons Dis
. 2024 May;
10(1):102.
PMID: 38760408
Lysosomal and synaptic dysfunctions are hallmarks in neurodegeneration and potentially relevant as biomarkers, but data on early Parkinson's disease (PD) is lacking. We performed targeted mass spectrometry with an established...
6.
Sixel-Doring F, Muntean M, Petersone D, Leha A, Lang E, Mollenhauer B, et al.
Mov Disord Clin Pract
. 2023 Dec;
10(12):1769-1776.
PMID: 38094641
Objectives: Rapid eye movement (REM) sleep behavior disorder (RBD) is proposed as an early diagnostic marker in Parkinson's disease (PD). We investigated the frequency of RBD during the progression of...
7.
Joza S, Hu M, Jung K, Kunz D, Arnaldi D, Lee J, et al.
Alzheimers Dement
. 2023 Jul;
20(1):91-102.
PMID: 37461299
Introduction: Isolated/idiopathic rapid eye movement sleep behavior disorder (iRBD) is a powerful early predictor of dementia with Lewy bodies (DLB) and Parkinson's disease (PD). This provides an opportunity to directly...
8.
Yu E, Krohn L, Ruskey J, Asayesh F, Spiegelman D, Shah Z, et al.
Ann Clin Transl Neurol
. 2023 Jul;
10(9):1682-1687.
PMID: 37401389
Synucleinopathies-related disorders such as Lewy body dementia (LBD) and isolated/idiopathic REM sleep behavior disorder (iRBD) have been associated with neuroinflammation. In this study, we examined whether the human leukocyte antigen...
9.
Somerville E, Krohn L, Yu E, Rudakou U, Senkevich K, Ruskey J, et al.
Neurobiol Aging
. 2023 Apr;
127:94-98.
PMID: 37032242
NPC1 encodes a lysosomal protein involved in cholesterol transport. Biallelic mutations in this gene may lead to Niemann-Pick disease type C (NPC), a lysosomal storage disorder. The role of NPC1...
10.
Joza S, Hu M, Jung K, Kunz D, Stefani A, Dusek P, et al.
Brain
. 2023 Mar;
146(8):3258-3272.
PMID: 36881989
The neurodegenerative synucleinopathies, including Parkinson's disease and dementia with Lewy bodies, are characterized by a typically lengthy prodromal period of progressive subclinical motor and non-motor manifestations. Among these, idiopathic REM...